Scott Laster, CEO, MiCare Path

This week, we interviewed Scott Laster. Scott is an award-winning entrepreneur with 20+ years of global medical device and digital health leadership. His time spent within an FTSE 100 and Top 4 Global Medical Device Manufacturer was focused on high-growth markets and transformational commercial business models. His roles drove deep knowledge of business structure, process excellence, and commercial execution – honed by leading teams for product launches (4 platform systems), acquisitions and corporate integrations (>$300M USD), and consistent commercial execution (10x market growth). Scott holds 5 patents and 4 provisional applications. He has also co-authored 4 peer-reviewed scientific posters and 3 peer-reviewed publications and has lectured globally at key industry events such as the International Society for Technology in Arthroplasty (ISTA) and International Congress for Joint Replacement (ICJR) , among others. As MiCare Path’s Chief Executive Officer, he oversees all functions across all aspects of the company.